Genetic risk could be used to identify patients who may have mitochondrial dysfunction, whether based on variation in known familial PD genes linked to mitochondria (particularly PINK1 and Parkin) or on mitochondria-associated genes drawn from large-scale genetic studies of PD (184, 185). Here, PINK1 is linked to Parkinson disease.